(Source: Repligen Corporation) - Product Sales Increase 31% to $19.8 Million - - Conference Call and Webcast Today at 8:30 a.m. ET - WALTHAM, Mass., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the third quarter and nine-month (year-to-date) periods ended September 30, 2015. Below are the Company's performance highlights, followed by updated financial guidance for the year 2015 and access information for today's webcast and conference call. Third Quarter and Year-to-Date Financial Highlights Product revenue for the third quarter of 2015 was $19.8 million...
↧